Weight Regain After Stopping GLP-1: What the Studies Show
It’s the question almost everyone asks eventually: “What happens if I stop?” You’ve lost the weight on a GLP-1 medication and you’re feeling good. The natural next thought is whether you can step off the treatment and keep the results. It’s a fair question, and it deserves an honest, evidence-based answer rather than either hype or scare stories. So let’s look at what the actual studies on weight regain after stopping GLP-1 medication show, and, just as importantly, what they don’t.
I’ll say the headline up front, because you deserve it straight: the research consistently shows that most people regain a large share of the lost weight after stopping these medications. But that finding comes with crucial context that changes how you should read it, including a hopeful part that most summaries skip. As a physiotherapist, my job here is to give you the whole picture so you can plan well, not panic.
What Happens When You Stop a GLP-1?
To understand weight regain, you first have to remember how these medications work. A GLP-1 lowers your appetite, it turns down hunger signals in the brain and slows how fast your stomach empties, so you naturally eat less. That reduced appetite is the engine of the weight loss. (I explain the full mechanism in my article on how these medications act in the body.)
Here’s the key: the medication doesn’t permanently reset your appetite. It holds it down while you’re taking it. Think of it like holding a spring compressed. As long as your hand is there, the spring stays down. Take your hand away, and the spring pushes back up. When you stop the medication, the appetite-lowering effect fades, hunger returns closer to where it started, and, for most people, eating rises with it. That’s the simple mechanism behind most weight regain after stopping GLP-1 medication.
The STEP 1 Study: What Happened After Semaglutide Stopped
The clearest evidence comes from following up on the big trials. In the STEP 1 trial, people took semaglutide for 68 weeks and lost, on average, close to 15% of their body weight. The important part for us is what a follow-up study tracked next: what happened in the year after they stopped.1
The result was sobering. In the year after stopping semaglutide, a follow-up period that did not include structured lifestyle support, participants regained roughly two-thirds of the weight they had lost.1 Not all of it, but a large majority. The weight that came off with the medication largely came back once the medication, and the appetite control it provided, was gone.
The SURMOUNT-4 Study: The Same Pattern With Tirzepatide
If STEP 1 were the only trial, you might wonder whether it was a fluke or specific to one drug. It isn’t. The SURMOUNT-4 trial tested the same question with tirzepatide, and it was designed specifically to measure what withdrawal does.3
Here’s how it worked. Everyone took tirzepatide for 36 weeks first. Then they were split into two groups: one kept taking it, the other switched to a placebo, a dummy injection with no active drug. Over the next year, the difference was stark. The group that kept taking tirzepatide lost even more weight. The group that switched to placebo regained, on average, about 14% of their body weight.3 A closer look found that among those who stopped, most, around 82%, regained more than a quarter of the weight they had originally lost.4
| SURMOUNT-4: after 36 weeks on tirzepatide, then one year… | Result |
|---|---|
| Group that kept taking tirzepatide | Continued to lose weight (further reduction)3 |
| Group that switched to placebo (stopped) | Regained about 14% of body weight, on average3 |
| Share of the “stopped” group who regained >25% of their lost weight | About 82%4 |
Two different medications, two large trials, the same core finding: stop the medication, and for most people the weight comes back. The lead researchers noted that this pattern shows up across at least five trials and multiple drug classes. It’s why many experts now describe obesity as a long-term condition that, for most people, needs long-term management rather than a one-off fix.3
Why Weight Regain Happens After Stopping
Here’s the part that matters most, because it removes the shame that often comes with regain. When people regain weight after stopping, they tend to blame themselves, a failure of willpower. The biology tells a different, kinder story.
Your body has something like a built-in thermostat for weight. When you lose a significant amount, your body often reacts as if something is wrong. It defends the higher weight it was used to, increasing hunger hormones, quieting fullness signals, and nudging you to eat more to get back to where it “expects” to be. This isn’t a character flaw; it’s a deep survival mechanism, and it’s one of the reasons keeping weight off has always been harder than losing it.
A GLP-1 medication works, in part, by counteracting that thermostat while you take it, holding hunger down against your body’s push to eat more. Remove the medication, and the thermostat is still set high, still pushing. Picture a thermostat cranked to a high temperature: the medication was the air conditioning holding the room cool. Switch off the AC, and the room drifts back to the temperature the thermostat is demanding.
It’s Not Just the Weight: The Health Gains Fade Too
There’s a part of the regain story that most headlines skip, and it matters more than the number on the scale. When people in the SURMOUNT-4 trial regained weight after stopping, many of their health improvements started to reverse as well.4
During the weight loss, markers like waist size, certain blood fats, and fasting insulin had improved. When the weight came back, a post-study analysis found those cardiometabolic gains tended to unwind in step with the regain, the more weight returned, the more the health benefits faded.4 In other words, weight regain isn’t only cosmetic. It can mean handing back real improvements in the health risks that made treatment worthwhile in the first place.
What Weight Regain After Stopping GLP-1 Does NOT Mean
Now the crucial balance, because it would be easy to read all of the above as “you’re trapped on this medication forever or you fail.” That is not what the research says, and honesty requires spelling out the limits of these studies.
Here’s the key nuance. These trials mostly tested stopping abruptly, often without a structured maintenance plan and, in some cases, without ongoing lifestyle support. They answered the question “what happens if you just stop?”, and the answer is, for most people, regain. But they did not test the questions many people actually care about. What happens if you taper gradually? What if you step down to a lower maintenance dose, or stop while following a strong exercise and nutrition plan built to hold the line? Those off-ramps simply weren’t what these trials measured.
How to Reduce the Risk of Weight Regain
So what can you actually do to lower your risk of weight regain after stopping GLP-1 treatment? The research doesn’t hand us a guaranteed formula. But combined with what we know about weight maintenance in general, a few principles stand out, and they’re worth knowing whether you plan to stay on treatment or eventually step off.
Protect your muscle on the way down. This is where my physiotherapy background gets loud. When you lose weight, some of the loss can be muscle, and muscle is a big driver of the calories you burn at rest. Lose too much of it, and your body burns less, which makes regain easier. Resistance exercise and enough protein help protect that muscle, keeping your metabolic “engine” stronger for the maintenance phase. I cover this in depth in my guides on muscle preservation during weight loss.
Treat maintenance as its own phase, with support. The through-line of all this research is that the maintenance phase is where weight is won or lost, and that ongoing support makes a difference. Whether that’s staying on a maintenance dose under medical guidance, or a carefully planned step-down paired with coaching and habit change, the common thread is a plan and a professional, not going it alone. Some structured weight-care programs are built specifically around this ongoing-support idea, with continued clinical oversight and progress tracking rather than a hand-off after the initial loss.
Have the stopping conversation before you stop. If and when you consider coming off a GLP-1, the evidence says to plan it with your prescriber rather than quitting cold. A gradual, supported approach hasn’t been proven to eliminate regain, but it’s a far more sensible bet than the abrupt stop the trials showed leads to it.
Weight Regain FAQ
Will I regain all the weight if I stop a GLP-1?
Not necessarily all of it, but the research shows most people regain a large share. In studies of both semaglutide and tirzepatide, participants who stopped regained a substantial portion of their lost weight within about a year.1,3 How much varies by person and, likely, by how the stopping is handled, abrupt stops without support showed the most regain.
How fast does weight regain happen after stopping?
It tends to be gradual over months rather than sudden, tracking the return of appetite as the medication clears. The trial follow-ups measured substantial regain over roughly a year after stopping.1,3
Why do I regain weight even if I keep eating carefully?
Because your body actively defends a higher weight. After weight loss, hunger hormones rise and fullness signals fall, a survival mechanism that pushes you to eat more. A GLP-1 counters this while you take it; once it’s stopped, that biological push returns. This is physiology, not a lack of willpower.
Does weight regain reverse the health benefits too?
It can. A post-study analysis of the SURMOUNT-4 trial found that cardiometabolic improvements, things like waist size, blood fats, and fasting insulin, tended to fade as weight was regained.4 The health gains are tied to keeping the weight off, not just achieving the loss once.
Does this mean I have to take a GLP-1 forever?
Not necessarily. The trials tested abrupt stopping, not gradual off-ramps or supported maintenance, so they can’t answer that question directly. Many experts frame obesity as a long-term condition that often needs long-term management. But what the right long-term plan looks like, staying on, stepping down, or stopping with strong support, is a decision for you and a qualified clinician.
The Bottom Line on Weight Regain After Stopping GLP-1
Here’s where I land as a physiotherapist. The evidence on weight regain after stopping GLP-1 medication is consistent and worth respecting: for most people, stopping leads to substantial regain within a year, and some of the health benefits fade along with it. Anyone starting one of these medications should understand that from the beginning, it changes the decision from “a course to finish” into “a long-term strategy to plan.”
But respect the good news too. This is not a story of hopeless dependence. The trials tested the crudest version of stopping, cold turkey, often without support, and that’s the scenario that goes badly. They didn’t test the smarter approaches: protecting muscle, building strong habits, tapering under guidance, or maintaining with ongoing professional support. Those are the levers you and a clinician can actually pull. The weight came off for a reason; keeping it off is a different job, and it’s one worth planning for deliberately rather than leaving to chance.
As always, this is educational information, not medical advice. Any decision to start, continue, or stop a GLP-1 medication belongs between you and a qualified clinician who knows your history.
- Wilding JPH, Batterham RL, Davies MJ, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553 to 1564. (Participants regained approximately two-thirds of lost weight in the year after stopping, without lifestyle-intervention support.)
- Rubino D, Abrahamsson N, Davies M, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight-loss maintenance: the STEP 4 randomized clinical trial. JAMA. 2021;325(14):1414 to 1425. (Withdrawal design; stopping led to regain, continuation maintained loss.)
- Aronne LJ, Sattar N, Horn DB, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial. JAMA. 2024;331(1):38 to 48. (Switching to placebo after 36 weeks led to ~14% mean weight regain; continuation produced further loss.)
- Horn DB, Linetzky B, Davies MJ, et al. Cardiometabolic parameter change by weight regain on tirzepatide withdrawal: a post hoc analysis of the SURMOUNT-4 trial. JAMA Intern Med. 2026;186(2):157 to 167. (~82% of the withdrawal group regained >25% of lost weight; cardiometabolic improvements reversed with regain.)
This article is for educational purposes only and does not constitute medical advice. It is not sponsored and does not endorse any specific medication or program. Decisions to start, continue, or stop a GLP-1 medication should be made with a qualified healthcare professional who knows your individual situation. Figures cited are drawn from the referenced primary literature.